Replimune Group, Inc.

REPL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Market Cap$850,185$785,499$1,011,173
- Cash$102,298$97,373$111,119$172,245
+ Debt$72,273$76,327$76,165$76,041
Enterprise Value$829,139$750,545$914,969
Revenue$0$0$0$0
% Growth
Gross Profit$0$0-$848$0
% Margin
EBITDA-$82,040-$89,429-$71,955-$64,950
% Margin
Net Income-$83,100-$86,693-$74,130-$66,340
% Margin
EPS Diluted-0.9-0.95-0.96-0.79
% Growth5.3%1%-21.5%
Operating Cash Flow-$81,212-$77,016-$53,731-$50,713
Capital Expenditures-$1,343-$2,740-$1,134-$1,800
Free Cash Flow-$82,555-$79,756-$54,865-$52,513
Replimune Group, Inc. (REPL) Financial Statements & Key Stats | AlphaPilot